Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

3rd Bacteriophage Therapy Summit 2021 - Boston, MA

Evvnt Promotion / evvnt
-
23.03.2021 - 25.03.2021  Online
Time: 08:00 - 17:00
 
Temi della conferenza
Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Sailaja Puttagunta, CMO, BiomX, Steven Theriault, CEO and CSO, Cytophage, Xavier Duportet, Co-Founder and CEO, Eligo Bioscience, Cara Fiore, Microbiologist, FDA, Office of Vaccines Research and Review and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/709133-2?pid=4832
Mr. Customer Services
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference Only - Industry (Early Bird and group discounts available): USD 1949.0, Conference Only - Academic/Start-Up (Early Bird and group discounts available): USD 1499.0
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceCharité International AcademyÄrzte der WeltEuropean Public Health Association (EUPHA)AGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteHelix - Forschung & Beratung Wien